Search Results - "Hilbers, M. F."

Controlling forward and backward rotary molecular motion on demand by Pfeifer, L., Crespi, S., van der Meulen, P., Kemmink, J., Scheek, R. M., Hilbers, M. F., Buma, W. J., Feringa, B. L.

“…Synthetic molecular machines hold tremendous potential to revolutionize chemical and materials sciences. Their autonomous motion controlled by external stimuli…”
Get full text

Rare Mutations in XRCC2 Increase the Risk of Breast Cancer by Park, D.J., Lesueur, F., Nguyen-Dumont, T., Pertesi, M., Odefrey, F., Hammet, F., Neuhausen, S.L., John, E.M., Andrulis, I.L., Terry, M.B., Daly, M., Buys, S., Le Calvez-Kelm, F., Lonie, A., Pope, B.J., Tsimiklis, H., Voegele, C., Hilbers, F.M., Hoogerbrugge, N., Barroso, A., Osorio, A., Giles, G.G., Devilee, P., Benitez, J., Hopper, J.L., Tavtigian, S.V., Goldgar, D.E., Southey, M.C.

“…An exome-sequencing study of families with multiple breast-cancer-affected individuals identified two families with XRCC2 mutations, one with a…”
Get full text

A JAK1 Selective Kinase Inhibitor and Tofacitinib Affect Macrophage Activation and Function by De Vries, L C S, Duarte, J M, De Krijger, M, Welting, O, Van Hamersveld, P H P, Van Leeuwen-Hilbers, F W M, Moerland, P D, Jongejan, A, D'Haens, G R, De Jonge, W J, Wildenberg, M E

“…Abstract Background Janus kinases (JAKs) mediate cytokine signaling involved in inflammatory bowel disease. The pan-JAK inhibitor tofacitinib has shown…”
Get full text

The impact of next generation sequencing on the analysis of breast cancer susceptibility: a role for extremely rare genetic variation? by Hilbers, FSM, Vreeswijk, MPG, van Asperen, CJ, Devilee, P

“…Women with a family history of breast cancer have an approximately twofold elevated risk of the disease. Even though an array of genes has been associated with…”
Get full text